Bicocca Open Archive

Logo unimib boa
CRISTOFERI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.724
AS - Asia 4.404
EU - Europa 4.018
SA - Sud America 707
Continente sconosciuto - Info sul continente non disponibili 364
AF - Africa 119
OC - Oceania 4
Totale 17.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.360
SG - Singapore 1.475
IT - Italia 1.414
CN - Cina 787
VN - Vietnam 763
HK - Hong Kong 611
RU - Federazione Russa 554
BR - Brasile 518
DE - Germania 481
SE - Svezia 455
IE - Irlanda 267
CA - Canada 251
GB - Regno Unito 232
FR - Francia 160
IN - India 158
BD - Bangladesh 101
KR - Corea 89
AR - Argentina 75
FI - Finlandia 64
ID - Indonesia 64
NL - Olanda 61
ES - Italia 53
TR - Turchia 50
CH - Svizzera 48
IQ - Iraq 46
AT - Austria 40
UA - Ucraina 39
ZA - Sudafrica 38
MX - Messico 37
PK - Pakistan 34
MY - Malesia 33
JP - Giappone 30
EC - Ecuador 29
PL - Polonia 29
PH - Filippine 26
CO - Colombia 24
SA - Arabia Saudita 24
DK - Danimarca 23
JM - Giamaica 22
VE - Venezuela 22
UZ - Uzbekistan 19
BE - Belgio 17
IL - Israele 14
LT - Lituania 14
CL - Cile 13
MA - Marocco 13
PY - Paraguay 13
KE - Kenya 12
EG - Egitto 11
CR - Costa Rica 10
ET - Etiopia 10
JO - Giordania 10
PT - Portogallo 9
TN - Tunisia 9
TW - Taiwan 9
HN - Honduras 8
TT - Trinidad e Tobago 8
AZ - Azerbaigian 7
CZ - Repubblica Ceca 7
GR - Grecia 7
RS - Serbia 7
NO - Norvegia 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
SY - Repubblica araba siriana 6
BO - Bolivia 5
DZ - Algeria 5
NI - Nicaragua 5
PA - Panama 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
GT - Guatemala 4
KZ - Kazakistan 4
MM - Myanmar 4
PE - Perù 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
CI - Costa d'Avorio 3
GD - Grenada 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
MU - Mauritius 3
OM - Oman 3
PS - Palestinian Territory 3
SN - Senegal 3
TH - Thailandia 3
UY - Uruguay 3
AL - Albania 2
AU - Australia 2
CG - Congo 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
IR - Iran 2
KH - Cambogia 2
MO - Macao, regione amministrativa speciale della Cina 2
SV - El Salvador 2
Totale 16.945
Salva come PNG Salva come JPEG
Città #
Singapore 909
Ann Arbor 862
Ashburn 723
San Jose 594
Hong Kong 590
Milan 442
Frankfurt am Main 369
Dublin 253
Chicago 241
Fairfield 231
New York 231
Chandler 221
Ho Chi Minh City 212
Los Angeles 206
Toronto 188
Hanoi 183
Wilmington 182
Council Bluffs 159
Hefei 153
Santa Clara 144
Dallas 137
Beijing 133
Rome 120
The Dalles 108
Seattle 105
Woodbridge 105
Houston 102
London 100
Boardman 99
Seoul 84
Cambridge 81
Princeton 75
Lauterbourg 71
Buffalo 70
Shanghai 68
Columbus 60
São Paulo 58
Dearborn 44
Denver 44
Moscow 44
Helsinki 43
Jakarta 43
Zurich 43
Phoenix 40
Florence 36
Orem 36
Lawrence 35
Munich 32
Monza 31
Altamura 28
Tokyo 27
Turin 27
Haiphong 26
Brooklyn 25
Montreal 25
Warsaw 25
Atlanta 24
Da Nang 24
San Diego 23
Johannesburg 21
Naples 21
Chennai 20
Pune 20
Rio de Janeiro 19
Bologna 18
Manchester 18
Ninh Bình 18
Nuremberg 18
Washington 18
Biên Hòa 17
Can Tho 17
Mumbai 17
Tashkent 17
Brentwood 16
Brussels 16
Jacksonville 16
Nanjing 16
Paris 16
Penang 16
Poplar 16
Vienna 16
Modena 15
New Delhi 15
Salt Lake City 15
San Francisco 15
Baghdad 14
Stockholm 14
Elk Grove Village 13
Kingston 13
Amsterdam 12
Andover 12
Baltimore 12
Bari 12
Boston 12
Genoa 12
Hải Dương 12
Istanbul 12
Mexico City 12
Campinas 11
Charlotte 11
Totale 10.025
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 635
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 440
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 416
Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement 400
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 381
Endocrinology and Metabolic Diseases (Including Diabetes) 374
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 374
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 368
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 361
Risk stratification in primary sclerosing cholangitis 361
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 357
Precision medicine in primary biliary cholangitis 352
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 338
RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT 331
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 319
New Therapeutic Targets in Autoimmune Cholangiopathies 317
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 315
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 307
Clinical treatment of cholangiocarcinoma: an updated comprehensive review 306
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 303
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain? 285
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 283
An update on novel pharmacological agents for primary sclerosing cholangitis 280
Artificial intelligence for precision medicine in autoimmune liver disease 278
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 270
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 268
Prognostic models in primary biliary cholangitis 265
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 264
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 259
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 255
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 254
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 251
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 250
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 250
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 248
Non-invasive imaging biomarkers in chronic liver disease 244
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 243
X marks the spot in autoimmunity 235
Fibrocystic liver disease 231
The immunobiology of female predominance in primary biliary cholangitis 226
COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy 223
Diagnostic Yield of Whole Exome Sequencing in Adult-onset Cholestatic Liver Disease 216
Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis 209
The Role of Epigenetics in Primary Biliary Cholangitis 209
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care 203
Malignancies in Primary Sclerosing Cholangitis--A Continuing Threat 202
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 202
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 200
Comment on "Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis" 199
The Time is Ripe for a Randomized Controlled Trial of Oral Vancomycin in Primary Sclerosing Cholangitis 185
A Smooth Esophageal Stricture Causing Dysphagia 182
Geoepidemiology and (epi-)genetics in primary biliary cholangitis 180
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 176
Individualizing Care: Management Beyond Medical Therapy 176
Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease? 171
Prevalence of upper gastrointestinal endoscopic findings in the community: A systematic review of studies in unselected samples of subjects 170
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 165
Systematic review-Pancreatic involvement in inflammatory bowel disease 159
Antioxidant treatment for acute pancreatitis 158
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 157
Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis 153
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 136
Primary Sclerosing Cholangitis 134
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 124
Individualizing Care: Management Beyond Medical Therapy 122
Elastography in Autoimmune Liver Diseases 122
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 119
Transient elastography in chronic liver disease: beware to the cut-offs! 113
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 81
Totale 17.340
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.035
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022434 0 0 0 80 43 41 14 42 39 32 53 90
2022/20231.439 118 329 125 93 152 181 108 69 101 47 76 40
2023/20241.363 45 65 67 134 145 271 181 28 69 98 45 215
2024/20252.845 195 303 153 143 233 130 191 111 302 421 260 403
2025/20267.138 934 531 494 770 683 346 1.046 309 519 597 411 498
2026/20271.895 287 369 780 459 0 0 0 0 0 0 0 0
Totale 17.340